SCHEMBL7965141

SCHEMBL7965141

CCOC(=O)Cc1c(C)[nH]c2cccc(OC)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.54
KDM4E B2RXH2 5/20 0.52
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 4/20 0.52
LMNA P02545 1/20 0.46
MAPT P10636 3/20 0.45
CHEK1 O14757 1/20 0.43
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
PKM P14618 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
GAA P10253 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KLK6 Q92876 1/20 0.41
USP2 O75604 2/20 0.41
HPGD P15428 1/20 0.41
KLK7 P49862 1/20 0.41
TSHR P16473 2/20 0.40
MAPK1 P28482 1/20 0.40
TUBB4A P04350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7933092 0.85 KDM4E (0.56) SLC2A1KDM4EALDH1A1HSD17B10MAPT
SCHEMBL8298676 0.83 KDM4E (0.47) SLC2A1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL27889099 0.82 LMNA (0.47) SLC2A1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL18277350 0.80 TSHR (0.50) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL4438498 0.79 KDM4E (0.49) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL18509726 0.77 SLC2A1 (0.55) SLC2A1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL7964644 0.77 SLC2A1 (0.44) SLC2A1KDM4EALDH1A1HSD17B10MAPT
SCHEMBL31487317 0.76 KDM4E (0.68) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL1165573 0.76 KDM4E (0.68) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL29121944 0.76 TSHR (0.47) KDM4EALDH1A1HSD17B10LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252084-B1 THERAPY FOR SEPSIS SHOCK ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0620215-B1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors LILLY CO ELI (US) 1999-08-18 EP disclosed
US-5684034-A INHIBITORS OF HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2, TREATMENT OF SEPTIC SHOCK, TRAUMA, RESPIRATORY DISORDERS, RHEUMATIC ARTHRITIS, INHIBITORS OF ARACHIDONIC ACID RELEASE ELI LILLY AND COMPANY (US) 1997-11-04 US disclosed
EP-0620215-A1 1H-indole-3-acetamide derivatives as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed